Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$27.66 - $121.06
Next Earnings Date
May 14 2025
Next Earnings Date
May 14 2025
Latest price
Market Cap | $4.27B |
EV | $2.59B |
Shares Outstanding | 128.76M |
Beta | 1.26 |
Analyst Rating | BUY |
Analyst Target Price | $132.00 |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | - |
EPS | -25.30% |
Operating Cash Flow | -55.10% |
Free Cash Flow | -54.90% |
Revenue | - |
EPS | -6.40% |
Operating Cash Flow | -10.20% |
Free Cash Flow | 10.70% |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | -20.44% |
ROCE 2024 | -20.41% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Vaxcyte, Inc.
PCVX
Sector
Healthcare
Industry
Biotechnology
CEO
Pickering, Grant
Employees
414
Website
vaxcyte.comIPO Date
2020-06-12
Headquarters
825 Industrial Road, Suite 300, San Carlos, California, 94070, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved